← All organizations

Synermore Biologics Co., Ltd.

For profitWebsite ↗

Also known as: Synermore Biologics Co., Ltd. | Synermore Biologics (Suzhou) Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 23, 2020

Timeline

2010s

Jun 1, 2013
Synermore Biologics Co., Ltd.— Founded

Drugs by trial phase (7 distinct, 7 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Anti-thymocyte Globulin (Rabbit)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (8)

NCT04644484Lead sponsorPhase 3Sep 23, 2020
NCT04363242Lead sponsorPhase 1Apr 9, 2020
NCT03961555Lead sponsorPhase 2Aug 31, 2019
NCT04495569Lead sponsorPhase 1/Phase 2Feb 26, 2019
NCT03254810Lead sponsorPhase 1Sep 26, 2017
NCT02956746Lead sponsorPhase 1/Phase 2Aug 1, 2016
NCT02391727Study directorPhase 1Mar 1, 2015
NCT02391727Lead sponsorPhase 1Mar 1, 2015

Details

Founded: Taipei, TW Jun 1, 2013
Last known activity: Sep 23, 2020